Reaction
Alopecia Scarring reporting signals
As of the last recalculation, Alopecia Scarring appears in 166 FAERS reports alongside 12 co-occurring drug terms. The strongest observed disproportionality signal is SIROLIMUS (PRR 142.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Sirolimus | 14 | 142.2 | 142.4 |
| Daspone | 10 | 136.9 | 137.1 |
| Dapsone Gel, 5% | 10 | 136.9 | 137.0 |
| Dapsone | 10 | 124.9 | 125.0 |
| Erlotinib | 9 | 123.1 | 123.2 |
| Clobetasol Propionate Ointment Usp, 0.05% | 8 | 102.3 | 102.4 |
| Clobetasol Propionate | 8 | 101.9 | 101.9 |
| Erlotinib Hydrochloride | 9 | 95.3 | 95.4 |
| Rifampin | 10 | 91.3 | 91.4 |
| Isotretinoin | 19 | 54.3 | 54.3 |
| Bendamustine Hydrochloride | 5 | 53.9 | 54.0 |
| Ixekizumab | 10 | 36.0 | 36.0 |